Back to Blog
Press Coverage•

Inclusive Healthcare: Celljevity's Mission to Broaden Access to Advanced Therapies

Celljevity's innovative approach to making advanced cellular therapies accessible to broader populations through strategic partnerships and global expansion.

BBN Times

External Publication

Read Original Article
Inclusive Healthcare: Celljevity's Mission to Broaden Access to Advanced Therapies

Inclusive Healthcare: Celljevity's Mission to Broaden Access to Advanced Therapies

This article from BBN Times explores Celljevity's innovative approach to making advanced cellular therapies accessible to broader populations through strategic partnerships and global expansion.

The article highlights how we're working to democratize access to cutting-edge longevity treatments through our expanding clinic network and patient support programs.

Read the full article on BBN Times

Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.